Related Experiment Video

Updated: Jul 17, 2026

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

Atherosclerosis and inflammation: insights from rheumatoid arthritis

Cecilia P Chung1, Ingrid Avalos, Paolo Raggi

  • 1Division of Rheumatology, Department of Medicine, Vanderbilt University, 1161 21st Avenue T-3219 MCN, Nashville, TN 37232, USA. c.chung@vanderbilt.edu

Clinical Rheumatology
|February 3, 2007
PubMed

Insights

Patients with rheumatoid arthritis (RA) experience higher rates of cardiovascular disease due to chronic inflammation. Managing RA inflammation and cardiovascular risks is crucial for improving patient outcomes and reducing mortality.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Cardiovascular disease (CVD) is a leading cause of death globally.
  • Atherosclerosis, once viewed as passive, is now understood as a dynamic inflammatory process.
  • Rheumatoid arthritis (RA) serves as a model for studying chronic inflammation's impact on atherosclerosis.

Purpose of the Study:

  • To review the intricate relationship between inflammation and atherosclerosis in the context of RA.
  • To highlight the increased cardiovascular morbidity and mortality observed in RA patients.
  • To discuss established and emerging cardiovascular risk factors relevant to RA.

Main Methods:

  • Literature review focusing on atherosclerosis, inflammation, and rheumatoid arthritis.
  • Analysis of evidence linking RA to accelerated coronary and extra-coronary atherosclerosis.
  • Synthesis of data on traditional and novel cardiovascular risk factors in RA patients.

Main Results:

  • Patients with RA exhibit significantly increased cardiovascular morbidity and mortality.
  • Accelerated atherosclerosis, both coronary and extra-coronary, is prevalent in RA.
  • Both traditional and novel cardiovascular risk factors contribute to CVD in RA.

Conclusions:

  • Effective management of RA necessitates a comprehensive approach to cardiovascular risk.
  • Controlling systemic inflammation is paramount in mitigating CVD risk in RA patients.
  • Rheumatologists should carefully assess cardiovascular risks, manage inflammation, and individualize treatment, including judicious use of anti-inflammatory medications and corticosteroids.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...